Would a coronavirus vaccine win Trump the election?


Will a COVID-19 vaccine be available this year? President Trump seems to think so — in fact, he told Geraldo Rivera in an interview Thursday it might be ready by Election Day. Though he said he is "rushing it," Trump hastened to insist he is "doing it not for the election," but because he wants "to save a lot of lives."
Be that as it may, the election timing — and possible political benefit — has clearly occurred to him, and he hardly conceals his abhorrence of defeat. But it's not clear that a vaccine would be an electoral guarantee.
On the one hand, I find plausible a secondary, economic bump for Trump, as is argued in this July article at Fox Business. Before the pandemic, two decades ago or whenever that was, Trump made the economy a major portion of his re-election pitch. Insofar as that's a strong selling point for keeping him around, a vaccine-induced economic rebound might well win him some votes. It likely would need to be a jobs rebound, though, not merely a rising stock market.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
On the other hand, I wonder what the early compliance rate with a COVID-19 vaccine may be. First there are the standard issue anti-vaxxers. A January poll found one in 10 Americans think vaccines are more dangerous than the diseases they prevent. Then there are the specific political fears and biases of this situation. On the right, some think the pandemic is wildly overblown and being used to introduce totalitarianism. It's difficult to imagine anyone who refuses a mask accepting an injection. On the left, I've encountered suspicion that Trump and "big pharma" are rushing the COVID-19 vaccine for their own gain. The number of Americans who will refuse "the Trump vaccine" won't be zero. And still more people will worry, on nonpolitical grounds, about a rushed vaccine's safety. They might decide to wait a while, just to be sure.
These reasons are how we get survey results saying the vaccine compliance rate might be as low as 50 percent. The Atlantic's Yascha Mounk has made a case for greater optimism, however, and he might be right. Hopefully we'll get the chance to find out sooner than later — maybe even, as Trump hopes, by Election Day.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Bonnie Kristian was a deputy editor and acting editor-in-chief of TheWeek.com. She is a columnist at Christianity Today and author of Untrustworthy: The Knowledge Crisis Breaking Our Brains, Polluting Our Politics, and Corrupting Christian Community (forthcoming 2022) and A Flexible Faith: Rethinking What It Means to Follow Jesus Today (2018). Her writing has also appeared at Time Magazine, CNN, USA Today, Newsweek, the Los Angeles Times, and The American Conservative, among other outlets.
-
UK-US trade deal: can Keir Starmer trust Donald Trump?
Today's Big Question White House insiders say an agreement is 'two weeks' away but can Britain believe it?
By Sorcha Bradley, The Week UK
-
Netanyahu's Qatar problem
Two of the prime minister's key advisers are accused of taking bribes from the Gulf state in exchange for favourable publicity
By Richard Windsor, The Week UK
-
Cartier at the V&A: a 'dazzling' show
The Week Recommends A 'once-in-a-lifetime' display of the French jeweller's 'exquisite' objects
By Irenie Forshaw, The Week UK
-
Why the GOP is nervous about Ken Paxton's Senate run
Today's Big Question A MAGA-establishment battle with John Cornyn will be costly
By Joel Mathis, The Week US
-
Bombs or talks: What's next in the US-Iran showdown?
Talking Points US gives Tehran a two-month deadline to deal
By Joel Mathis, The Week US
-
The JFK files: the truth at last?
In The Spotlight More than 64,000 previously classified documents relating the 1963 assassination of John F. Kennedy have been released by the Trump administration
By The Week Staff
-
Are we really getting a government shutdown this time?
Talking Points Democrats rebel against budget cuts by Trump, Musk
By Joel Mathis, The Week US
-
Will Trump lead to more or fewer nuclear weapons in the world?
Talking Points He wants denuclearization. But critics worry about proliferation.
By Joel Mathis, The Week US
-
Why Trump and Musk are shutting down the CFPB
Talking Points And what it means for American consumers
By Joel Mathis, The Week US
-
Are we now in a constitutional crisis?
Talking Points Trump and Musk defy Congress and the courts
By Joel Mathis, The Week US
-
What can Democrats do to oppose Trump?
Talking Points The minority party gets off to a 'slow start' in opposition
By Joel Mathis, The Week US